How did we take care of our older cancer patients during the first COVID-19 wave? The French experience.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 22 12 2020
revised: 07 02 2021
accepted: 10 02 2021
pubmed: 17 4 2021
medline: 24 6 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The management of older cancer patients has been highly challenging for clinicians in a health-care system operating at maximum capacity during the COVID-19 pandemic. We analyzed data from 9 different institutions. The primary endpoint was to assess the prevalence of adapted patient care during the pandemic for elderly cancer patients. The secondary endpoint was to assess the incidence of hospitalization and mortality due to COVID-19. All patients were older than 65years of age. We analyzed data from 332 outpatients' case files between 9th of March and 30th of April 2020. The median age was 75years (range: 65-101) and 53% were male. Because of the COVID-19 pandemic, more than half of the outpatients received modified patient care, defined as postponement or cancellation of surgery, irradiation scheme adapted, systemic treatment or the use of telemedicine. Among patients with localized cancer, 60% had a change in management strategy due to the pandemic. Changes in management strategy were made for 53% of patients at the metastatic stage. GCSF was used , in 83% of patients, increasing considerably in the context of the pandemic. Sixty-nine percent of physicians used telemedicine. In the final analysis, only one patient was hospitalized for COVID-19 infection. No deaths due to COVID-19 were reported in elderly cancer patients during this time period. Our study is the first to assess modification of patient care in elderly cancer outpatients during an epidemic. With this unprecedented crisis, our objective is to protect our patients from infection via protective barrier measures and social distancing, but also to guarantee the continuity of cancer care without overexposing this fragile population. Physicians were able to adapt their practice and used new forms of management, like telemedicine.

Sections du résumé

BACKGROUND BACKGROUND
The management of older cancer patients has been highly challenging for clinicians in a health-care system operating at maximum capacity during the COVID-19 pandemic.
PATIENTS AND METHODS METHODS
We analyzed data from 9 different institutions. The primary endpoint was to assess the prevalence of adapted patient care during the pandemic for elderly cancer patients. The secondary endpoint was to assess the incidence of hospitalization and mortality due to COVID-19. All patients were older than 65years of age.
RESULTS RESULTS
We analyzed data from 332 outpatients' case files between 9th of March and 30th of April 2020. The median age was 75years (range: 65-101) and 53% were male. Because of the COVID-19 pandemic, more than half of the outpatients received modified patient care, defined as postponement or cancellation of surgery, irradiation scheme adapted, systemic treatment or the use of telemedicine. Among patients with localized cancer, 60% had a change in management strategy due to the pandemic. Changes in management strategy were made for 53% of patients at the metastatic stage. GCSF was used , in 83% of patients, increasing considerably in the context of the pandemic. Sixty-nine percent of physicians used telemedicine. In the final analysis, only one patient was hospitalized for COVID-19 infection. No deaths due to COVID-19 were reported in elderly cancer patients during this time period.
CONCLUSION CONCLUSIONS
Our study is the first to assess modification of patient care in elderly cancer outpatients during an epidemic. With this unprecedented crisis, our objective is to protect our patients from infection via protective barrier measures and social distancing, but also to guarantee the continuity of cancer care without overexposing this fragile population. Physicians were able to adapt their practice and used new forms of management, like telemedicine.

Identifiants

pubmed: 33858619
pii: S0007-4551(21)00128-4
doi: 10.1016/j.bulcan.2021.02.007
pmc: PMC8023196
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

589-595

Informations de copyright

Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Carole Helissey (C)

Military hospital Begin, clinical research unit, 69, avenue de Paris, 94160 Saint-Mandé, France. Electronic address: carole.helissey@gmail.com.

Djamel Ghebriou (D)

AP-HP, Sorbonne université, institut universitaire de cancérologie, Tenon university hospital, department of oncology, 4, rue de la Chine, 75020 Paris, France.

Anatole Cessot (A)

Clinique Hartmann, department of medical oncology, 26, boulevard Victor-Hugo, 92200 Neuilly-sur-Seine, France.

Laurys Boudin (L)

Military hospital Sainte-Anne, department of medical oncology, 2, boulevard Sainte-Anne, BP600, 83000 Toulon, France.

Caroline Prieux (C)

Military Hospital Percy, department of gastroenterology, 2, rue Lieutenant-R.-Batany, 92140 Clamart, France.

Emilie Romeo (E)

Military hospital Sainte-Anne, department of medical oncology, 2, boulevard Sainte-Anne, BP600, 83000 Toulon, France.

Anotine Schernberg (A)

Hôpital Tenon, department of radiation oncology, 4, rue de la Chine, 75020 Paris, France.

Noémie Grellier (N)

Hôpital Henri-Mondor, department of radiation oncology, 1, rue Gustave-Eiffel, 94000 Créteil, France.

Charlotte Joly (C)

Hôpital Henri-Mondor, department of medical oncology, 1, rue Gustave-Eiffel, 94000 Créteil, France.

Olivier Bauduceau (O)

Clinique Hartmann, department of radiation oncology, 26, boulevard Victor-Hugo, 92200 Neuilly-sur-Seine, France.

Constance Thibault (C)

AP-HP, Centre, HEGP, department of medical oncology, 20, rue Leblanc, 75015 Paris, France.

Elodie Mamou (E)

Military hospital Begin, clinical research unit, 69, avenue de Paris, 94160 Saint-Mandé, France.

Gauthier Raynal (G)

Clinique Métivet, department of urology, 48, rue d'Alsace Lorraine, 94100 Saint-Maur-des-Fossés, France.

Sophie Serey Eiffel (S)

Clinique Métivet, department of urology, 48, rue d'Alsace Lorraine, 94100 Saint-Maur-des-Fossés, France.

Hervé Le Floch (H)

Military hospital Percy, department of pulmonology, 2, rue Lieutenant-R.-Batany, 92140 Clamart, France.

Damien Ricard (D)

Military hospital Percy, department of neurology, 2, rue Lieutenant-R.-Batany, 92140 Clamart, France.

Laurent Brureau (L)

CHU de Pointe-à-Pitre, université Antilles, université Rennes, Inserm, EHESP, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR-S 1085, 97110 Pointe-à-Pitre, Guadeloupe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH